Skip to main navigation
Skip to search
Skip to main content
New Jersey Institute of Technology Home
Help & FAQ
Link opens in a new tab
Search content at New Jersey Institute of Technology
Home
Profiles
Research units
Facilities
Federal Grants
Research output
Press/Media
Melatonin: A double-edged sword for cancer treatment
Paula Nuñez
,
Sara C. Zapico
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Melatonin: A double-edged sword for cancer treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Melatonin
100%
Cancer Treatment
100%
Double-edged Sword
100%
Oxidative Stress
33%
Free Radicals
26%
Cytotoxic Effect
26%
Antioxidant
20%
Tumor
13%
Apoptotic Pathway
13%
Reactive Oxygen Species
13%
Glutathione
13%
Hematological Malignancies
13%
Ewing Sarcoma Family of Tumors
13%
Extrinsic Apoptosis
13%
Indolamine
13%
Circadian Rhythm
6%
Biological Systems
6%
Signaling Pathway
6%
Breast Cancer
6%
Harmful Effects
6%
Synergistic Effect
6%
Systemability
6%
Hydrogen Peroxide
6%
Peroxide
6%
Immune System
6%
Physiological Function
6%
Two-path
6%
Hypochlorous Acid
6%
Cell Death Pathways
6%
Mannitol
6%
Free Radical Scavenger
6%
Catalase
6%
Glioma
6%
Cancer Patients
6%
Antioxidant Enzymes
6%
Antioxidant Enzyme Activity
6%
Colorectal Cancer
6%
Reactive Intermediates
6%
Antioxidant Activity
6%
Tumor Malignancy
6%
Biliary Cancer
6%
Glutathione Peroxidase (GSH-Px)
6%
FasR
6%
Systemic Manifestations
6%
Potent Antioxidant
6%
Pineal Gland
6%
Dismutase
6%
Double Effect
6%
Intrinsic Pathway
6%
Glutathione Reductase
6%
Peroxyl Radicals
6%
Peroxynitrite Anion
6%
Dual Action
6%
FasL
6%
Antioxidant Function
6%
Glucose-6-phosphate Dehydrogenase (G6PD)
6%
Hydroxyl Radical ([rad]OH)
6%
Antiproliferative Effect
6%
Chemotherapy Effect
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Melatonin
100%
Antioxidant
46%
Free Radical
26%
Cytotoxicity
26%
Antiinfective Agent
13%
Glutathione
13%
Reactive Oxygen Metabolite
13%
Hematologic Malignancy
13%
Ewing Sarcoma
13%
Indoleamine
13%
Enzymes
13%
Breast Cancer
6%
Hydrogen Peroxide
6%
Glutathione Reductase
6%
Peroxynitrite
6%
Hydroxyl Radical
6%
Mannitol
6%
Catalase
6%
Peroxy Radical
6%
Colorectal Carcinoma
6%
Antioxidant Capacity
6%
Glutathione Peroxidase
6%
Bile Duct Cancer
6%
Glucose 6 Phosphate Dehydrogenase
6%
Chemotherapy Regimens
6%
Glioma
6%
Peroxide
6%